<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:circular="https://rhnvrm.github.io/stock-market-circulars/ns"><channel><title>Rssoftware - Stock Market Circulars</title><link>https://rhnvrm.github.io/stock-market-circulars/tags/rssoftware/</link><description>Regulatory circulars from NSE, BSE, and SEBI with AI-powered summaries</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Mon, 13 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://rhnvrm.github.io/stock-market-circulars/tags/rssoftware/feed.xml" rel="self" type="application/rss+xml"/><item><title>NSE Trade for Trade Segment Shift - 14 Securities Effective April 17, 2026</title><link>https://rhnvrm.github.io/stock-market-circulars/circulars/nse/2026/nse-2026-04-13-2ac82da7769984cc-trade-for-trade/</link><pubDate>Mon, 13 Apr 2026 00:00:00 +0530</pubDate><guid>https://rhnvrm.github.io/stock-market-circulars/circulars/nse/2026/nse-2026-04-13-2ac82da7769984cc-trade-for-trade/</guid><description>NSE Surveillance has decided to shift 14 securities from Rolling segment (EQ) to Trade for Trade segment (BE) with a 5% price band effective April 17, 2026, as part of ongoing market surveillance review.</description><circular:source>nse</circular:source><circular:category>trading</circular:category><circular:impact>high</circular:impact><circular:severity>high</circular:severity><circular:importance>high</circular:importance><circular:id>2ac82da7769984cc</circular:id><circular:pdfUrl>https://nsearchives.nseindia.com/content/circulars/SURV73734.zip</circular:pdfUrl><circular:stock>ASTRON</circular:stock><circular:stock>BAFNAPH</circular:stock><circular:stock>BANKA</circular:stock><circular:stock>CTE</circular:stock><circular:stock>FILATFASH</circular:stock><circular:stock>LASA</circular:stock><circular:stock>MCLEODRUSS</circular:stock><circular:stock>RSSOFTWARE</circular:stock><circular:stock>SAMBHAAV</circular:stock><circular:stock>VITAL</circular:stock><circular:stock>VIVIMEDLAB</circular:stock><circular:stock>VLEGOV</circular:stock><circular:stock>ACCURACY</circular:stock><circular:stock>FCSSOFT</circular:stock><category>trade-for-trade</category><category>surveillance</category><category>price-band</category><category>segment-shift</category><category>be-series</category><category>market-safety</category><category>astron</category><category>bafnaph</category><category>banka</category><category>cte</category><category>filatfash</category><category>lasa</category><category>mcleodruss</category><category>rssoftware</category><category>sambhaav</category><category>vital</category><category>vivimedlab</category><category>vlegov</category><category>accuracy</category><category>fcssoft</category><content:encoded><![CDATA[<h2 id="summary">Summary</h2>
<p>NSE Surveillance (Circular Ref. No. 269/2026, Download Ref: NSE/SURV/73734) has directed the shift of 14 securities from the Rolling segment (series: EQ/SM) to the Trade for Trade segment (series: BE/ST) with a price band of 5% or lower, effective April 17, 2026 (Friday). The action is taken under Capital Market Segment Trading Regulations Part-A, Regulation 2.6, as part of a periodic surveillance review to ensure market safety and investor protection. A second annexure (Annexure-2) lists securities that will continue in the Trade for Trade segment (series: BE/BZ or ST/SZ).</p>
<h2 id="key-points">Key Points</h2>
<ul>
<li>14 securities shifted from Rolling segment (EQ/SM) to Trade for Trade segment (BE/ST) effective April 17, 2026</li>
<li>A 5% or lower price band will apply to all shifted securities</li>
<li>Shifted securities will no longer be available in the rolling segment (EQ/SM series)</li>
<li>Settlement will be on a trade-to-trade basis — no netting off will be permitted</li>
<li>All 14 securities triggered the shift based on criteria: Price Earnings Multiple, Price Variation &amp; Market Capitalization</li>
<li>Additional securities in Annexure-2 will continue in Trade for Trade segment (BE/BZ or ST/SZ)</li>
<li>The action is purely a market surveillance measure and should not be construed as adverse action against the concerned companies</li>
</ul>
<h2 id="regulatory-changes">Regulatory Changes</h2>
<p>Under Capital Market Segment Trading Regulations Part-A, Regulation 2.6, the listed securities are moved to the Trade for Trade (T2T) segment. This removes the availability of normal rolling settlement for the affected scrips. Criteria for shifting securities to/from Trade for Trade are published at <a href="https://www.nseindia.com/regulations/movement-securities-periodic-review">https://www.nseindia.com/regulations/movement-securities-periodic-review</a>.</p>
<h2 id="compliance-requirements">Compliance Requirements</h2>
<ul>
<li><strong>NSE Members</strong>: Must take adequate precautions while trading in the affected securities</li>
<li><strong>Members</strong>: Must note that settlement will be done on a trade-to-trade basis with no netting off allowed</li>
<li><strong>Brokers/Traders</strong>: Must ensure clients are informed that the affected securities are no longer available in the EQ/SM (rolling) series</li>
<li><strong>Queries</strong>: Members may contact NSE Surveillance at <a href="mailto:surveillance@nse.co.in">surveillance@nse.co.in</a> for further clarification</li>
</ul>
<h2 id="important-dates">Important Dates</h2>
<ul>
<li><strong>Circular Date</strong>: April 13, 2026</li>
<li><strong>Effective Date</strong>: April 17, 2026 (Friday) — Trade for Trade restrictions apply from market open</li>
</ul>
<h2 id="impact-assessment">Impact Assessment</h2>
<p>All 14 affected securities will face significantly reduced liquidity and trading flexibility from April 17, 2026. The 5% price band limits intraday price movement, and the elimination of netting in settlement increases capital requirements for traders. Investors holding these securities should note:</p>
<ul>
<li><strong>ASTRON</strong> (Astron Paper &amp; Board Mill Limited | INE646X01014)</li>
<li><strong>BAFNAPH</strong> (Bafna Pharmaceuticals Limited | INE878I01022)</li>
<li><strong>BANKA</strong> (Banka Bioloo Limited | INE862Y01015)</li>
<li><strong>CTE</strong> (Cambridge Technology Enterprises Limited | INE627H01017)</li>
<li><strong>FILATFASH</strong> (Filatex Fashions Limited | INE185E01021)</li>
<li><strong>LASA</strong> (Lasa Supergenerics Limited | INE670X01014)</li>
<li><strong>MCLEODRUSS</strong> (McLeod Russel India Limited | INE942G01012)</li>
<li><strong>RSSOFTWARE</strong> (R.S. Software (India) Limited | INE165B01029)</li>
<li><strong>SAMBHAAV</strong> (Sambhaav Media Limited | INE699B01027)</li>
<li><strong>VITAL</strong> (Vital Chemtech Limited | INE0L4K01016)</li>
<li><strong>VIVIMEDLAB</strong> (Vivimed Labs Limited | INE526G01021)</li>
<li><strong>VLEGOV</strong> (VL E Governance &amp; IT Solutions Limited | INE03HW01020)</li>
<li><strong>ACCURACY</strong> (Accuracy Shipping Limited | INE648Z01023)</li>
<li><strong>FCSSOFT</strong> (FCS Software Solutions Limited | INE512B01022)</li>
</ul>
<p>The shift signals heightened regulatory scrutiny due to abnormal price/earnings multiples, price variation, and market capitalization concerns. Retail and institutional participants should exercise caution and reassess position sizing given the restricted settlement mechanism.</p>
]]></content:encoded></item></channel></rss>